RetroPerc® and Dornier MedTech America, Inc. Announce Multi-Year Exclusive US Distribution Agreement
JERSEY CITY, NJ (April 27, 2023) — RetroPerc®, Inc. announced a multi-year exclusive US distribution agreement with Dornier MedTech America, Inc. to distribute its FDA-cleared nephrostomy puncture device.
“Dornier has a long history of innovation and excellence in endourology,” said Jason B. Wynberg, CEO of RetroPerc®. “They boast a highly skilled and motivated national sales force with deep knowledge of kidney stone surgery and the PCNL procedure. We very much look forward to this partnership.”
Brock Faulkner, Chief Executive Officer of Dornier MedTech America said: “RetroPerc® is an innovative, easy-to-use device that enables a more accurate and safe iteration of the PCNL procedure. We are excited to bring this great product to more patients, urologists, and their staff.”
Dornier will be demonstrating the RetroPerc® kit at the upcoming 2023 American Urological Association (AUA) meeting in Chicago from April 28 – May 1.
About RetroPerc®
RetroPerc® is an intuitive flexible puncture wire set that enables Urologists to create their own nephrostomy by advancing a puncture wire from the ‘inside to outside’ direction, guided by a pre-positioned flexible ureteroscope. This simplifies and makes the percutaneous nephrolithotomy (PCNL) procedure safer for patients and requires less radiation than antegrade nephrostomy punctures.
For more information about RetroPerc®, please visit www.retroperc.com
About Dornier MedTech
Dornier MedTech is a medical device company headquartered in Munich, Germany, and is a full subsidiary of Advanced MedTech. As a pioneer in the field of urology, Dornier is one of the most trusted names in the industry.
Dornier continues to drive clinical performance and spearhead innovation in urology, launching several pioneering technologies and revolutionary therapies in recent years. As the world’s first MDR-certified integrated urology company, and one of the original founders of the Urology Care Foundation (formerly known as the American Foundation for Urologic Diseases), it takes pride in holding itself to the highest standards of patient safety and product efficacy.
Today, Dornier is pushing the envelope in digital urology to provide holistic care to patients seeking treatment and community support in their recovery journey, through online and in-person channels. Trusted by thousands of physicians and patients, Dornier is committed to serving and supporting our urology communities worldwide.
For more information about Dornier MedTech America, Inc. please visit www.dornier.com/americas/
Press Contact:
Ninelle Giller; 248-975-7372; info@retroperc.com